Ticker League

SELLAS Life Sciences Group (SLS) Free Cash Flow Bridge

Pinpoint what moved SELLAS Life Sciences Group's FCF from TTM through Q1 2025 to TTM through Q1 2026 — operating cash flow shifts and capex changes, each driver sized in dollars.

Analysis
TTM

FCF YoY

+16.45%

OCF YoY

+16.45%

Capex Change

+0.0

FCF Conversion Δ

Free cash flow bridge for SELLAS Life Sciences Group (SLS) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Free cash flow: $5.55M

FCF bridge breakdown for SELLAS Life Sciences Group (SLS) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Free Cash Flow-$33.7M
  • Operating Cash Flow$5.55M
  • Capital Expenditure$0.00
  • Free Cash Outflow-$28.2M
Identity check: drivers reconcile to ΔNI within $0.00
Want to see how cash flow is built up?Cash Flow Waterfall

Frequently asked questions

Data & methodology

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation